Announced Fri, 25 Sept, 2026 · 18:16 IST

Trading window closure for Q2 and H1 FY27 results

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹76.74

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+0.9% vs market

Pharmaceuticals peers, median of 172sector-1.5%+0.8% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7-1.6+0.9-1.5+0.8

Next day

+0.3-0.6+0.9-1.0+1.3

-3.5-0.8-2.7-1.9-1.6

-1.4-2.1+0.8-2.5+1.1

+0.3-2.1+2.4-3.4+3.7

-4.9-0.8-4.0-2.4-2.5

-7.5-3.8-3.7-4.2-3.2

15d

-11.4-6.9-4.5-7.8-3.6

-16.6pendingpending-6.4-10.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Concord Drugs has closed its trading window from 01 October 2026 until 48 hours after the announcement of unaudited financial results for the quarter and year ending 30 September 2026. During this period, directors, designated employees, insiders and their immediate relatives cannot trade in the company's shares. The board meeting date for considering the results will be announced separately.

Likely market impact

Routine compliance filing. No direct impact on shareholders. Signals upcoming Q2 FY27 results announcement.